Published on
October 17, 2024
- 20:00 GMT
Fiagon GmbH Receives FDA Clearance for Spine Platform and Showcases Innovative Solutions at NASS and EUROSPINE 2024
BERLIN, GERMANY, October 17, 2024 /EINPresswire.com/ -- Fiagon GmbH is proud to announce a series of significant achievements, including the recent FDA clearance of the expanded Spine Platform and commercial launch in the United States at NASS 2024. …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
